Amodaia is a boutique life science consultancy helping biotech, pharma, and medtech teams deliver strategy and content that works – fast, compliant, and credible.
We combine deep regulatory expertise, medical clarity, commercial storytelling, and real-world patient insight to support the full journey – from preclinical development to market access, fundraising, and global launch.
We bring big pharma quality with boutique speed – helping biotech, pharma, and medtech teams move faster, without compromising compliance or credibility.
Our team combines senior regulatory writers, scientific strategists, creative thinkers, and investor-ready storytellers. Every deliverable is grounded in evidence, shaped by experience, and focused on outcomes that matter.
We don’t just understand your science. We know how to position it – to regulators, payers, clinicians, and capital partners alike.
Whether you are preparing an IND, aligning to EMA expectations, planning your HEOR toolkit, or raising a Series A – we bring the experience, speed, and strategy to get you there.
We support clients with:
Regulatory and medical writing
Access and reimbursement strategy
Brand messaging and omnichannel comms
Fundraising decks and investor outreach
Scientific storytelling and capital advisory
Senior experts write our content. No bloated teams. No junior handoffs. Just fast, credible, compliant deliverables – designed to land first time.
We are not a legacy medcomms agency or generalist shop. We are lean, senior, and focused on outcomes that move your business forward.
Expert-led: You work directly with senior consultants, writers, and strategists.
Faster delivery: We don not do handoffs. We do high velocity with high quality.
Human-first: Our work is shaped by lived patient experience, not buzzwords.
Cross-functional: We span science, strategy, capital, and compliance.
Trusted by global teams: We support clients across the UK, EU, US, and APAC.